Article Versions Notes

Wang X, Han W, Zhang Y, Zong Y, Tan N, Zhang Y, Li L, Liu C, Liu L. Soluble Epoxide Hydrolase Inhibitor t-AUCB Ameliorates Vascular Endothelial Dysfunction by Influencing the NF-κB/miR-155-5p/eNOS/NO/IκB Cycle in Hypertensive Rats. Antioxidants. 2022; 11(7):1372. https://doi.org/10.3390/antiox11071372

Wang, Xiaorui, Wenwen Han, Yi Zhang, Yi Zong, Na Tan, Yan Zhang, Li Li, Chang Liu, and Limei Liu. 2022. "Soluble Epoxide Hydrolase Inhibitor t-AUCB Ameliorates Vascular Endothelial Dysfunction by Influencing the NF-κB/miR-155-5p/eNOS/NO/IκB Cycle in Hypertensive Rats" Antioxidants 11, no. 7: 1372. https://doi.org/10.3390/antiox11071372

Wang, X., Han, W., Zhang, Y., Zong, Y., Tan, N., Zhang, Y., Li, L., Liu, C., & Liu, L. (2022). Soluble Epoxide Hydrolase Inhibitor t-AUCB Ameliorates Vascular Endothelial Dysfunction by Influencing the NF-κB/miR-155-5p/eNOS/NO/IκB Cycle in Hypertensive Rats. Antioxidants, 11(7), 1372. https://doi.org/10.3390/antiox11071372